Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Trial of Epirubicin, Carboplatin & Capecitabine in Adult Cancer Patients

NCT00021047 is registered in ClinicalTrials.gov with National Institutes of Health Clinical Center (CC) as lead sponsor.

NCT NCT00021047
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00021047 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Trial of Epirubicin, Carboplatin & Capecitabine in Adult Cancer Patients
Lead sponsor
National Institutes of Health Clinical Center (CC)
Phase
Phase 1/2
Overall status
Completed
Start date
July 31, 2001
Completion date
June 30, 2004
Enrollment
Not reported
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal cancer, extrahepatic bile duct cancer, gastric cancer, head and neck cancer, liver cancer, unspecified adult solid tumor, protocol specific